Cite Filings / AVTX / 0001628280-19-015272

Feed Companies Filings Check

Sign in

425

Prospectus/Communication re Business Combination

Avalo Therapeutics, Inc. Filed 2019-12-23 Acc 0001628280-19-015272

Documents 1

425 Prospectus/Communication re Business Combination , december2019investorpresen.htm

Around this filing

2019-12-30 CORRESP Correspondence Between Filers and SEC Staff
2019-12-30 S-4/A Registration Statement - Business Combination
2019-12-27 UPLOAD SEC-generated Letter
2019-12-23 425 Prospectus/Communication re Business Combination
2019-12-23 8-K Other events
2019-12-20 S-4 Registration Statement - Business Combination
2019-12-11 425 Prospectus/Communication re Business Combination

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading december2019investorpresen.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…